Big Drug Companies See Us as Profits — Not People

March 13, 2019

Americans continue to pay the highest drug prices in the world while the big drug companies rake in billions. We shouldn’t have to choose between buying medication and buying food for our families. Congress: put people before profits. Stop the greed. Cut drug prices now.

Spotlight

LFB

LFB is a biopharmaceutical group that develops, manufactures and markets medicinal products for the treatment of serious and often rare diseases in several major therapeutic fields, namely Hemostasis, Immunology and Intensive Care. With most of its products indicated for serious and rare diseases, LFB is a major player in this area. The LFB Group is the leading manufacturer of plasma-derived medicinal products in France and 5th worldwide and is also among the leading European companies for the development of new-generation proteins and treatments based on biotechnologies.

OTHER VIDEOS

The Future of Pharmacy Management Software

video | November 17, 2022

Welcome to the future of pharmacy management software! Axys is built from the ground up on the most modern technology. Not the most modern technology in long-term care....

Watch Now

How advanced simulation accelerates new technology development

video | November 22, 2022

PureBlue Water and AM-Team work together in this European CrossRoads2 Sustainable Energy project to develop a novel technology to remove pharmaceutical residues from wastewater....

Watch Now

Smart Quality Is The Future Of Quality Management

video | November 23, 2022

Smart Quality is a term that describes a new way of thinking about quality control and improvement. It emphasizes using data and technology to drive value and improve performance....

Watch Now

Bravado Pharmaceuticals - Hei-VAP Rotary Evaporator

video | November 16, 2022

Bravado Pharmaceuticals is a state-of-the-art, innovative pharmaceutical contract development organization....

Watch Now

Spotlight

LFB

LFB is a biopharmaceutical group that develops, manufactures and markets medicinal products for the treatment of serious and often rare diseases in several major therapeutic fields, namely Hemostasis, Immunology and Intensive Care. With most of its products indicated for serious and rare diseases, LFB is a major player in this area. The LFB Group is the leading manufacturer of plasma-derived medicinal products in France and 5th worldwide and is also among the leading European companies for the development of new-generation proteins and treatments based on biotechnologies.

Events